Adelene Q. Perkins
2012
In 2012, Adelene Q. Perkins earned a total compensation of $1.7M as President and Chief Executive Officer at Infinity Pharmaceuticals, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $293,031 |
|---|---|
| Option Awards | $895,473 |
| Salary | $536,000 |
| Other | $8,466 |
| Total | $1,732,970 |
Perkins received $895.5K in option awards, accounting for 52% of the total pay in 2012.
Perkins also received $293K in non-equity incentive plan, $536K in salary and $8.5K in other compensation.
Rankings
In 2012, Adelene Q. Perkins' compensation ranked 4,042nd out of 11,487 executives tracked by ExecPay. In other words, Perkins earned more than 64.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,042 out of 11,487 | 65th |
Division Manufacturing | 1,400 out of 4,253 | 67th |
Major group Chemicals And Allied Products | 316 out of 1,198 | 74th |
Industry group Drugs | 190 out of 920 | 79th |
Industry Pharmaceutical Preparations | 145 out of 700 | 79th |
Source: SEC filing on April 27, 2015.
Perkins' colleagues
We found three more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2012.